武汉大学人民医院湖北省人民医院

院内导航

邱涛 泌尿外科学
副教授，副主任医师，硕士生导师，党支部书记，OPO办公室副主任

A+ A-

导师介绍

姓名	邱涛
出生年月	1984年4月
单位	武汉大学人民医院器官移植科
所属学科	临床医学-外科学
职务、职称及头衔	副教授，副主任医师，硕士生导师，党支部书记，OPO办公室副主任
E-mail	qiutao@whu.edu.cn
联系方式	027-88041911转81849或13995632367
研究方向	1.器官缺血再灌注损伤 2.移植免疫耐受
个人简介	从事器官移植工作逾10年，参加和完成各类肾脏移植手术逾千例，在肾移植领域具有丰富的理论知识和临床经验，擅长肾脏移术后个体化用药，BKV感染，排斥反应预防与控制。主持国家自然科学基金1项，主持或参与国家及省市级科研项目十余项，发表SCI论文40篇，核心期刊论文30余篇，参编著作2部。长期致力于移植免疫耐受，缺血再灌注损伤的研究。
学术任职与荣誉	中华医学会器官移植分会青年委员会委员，中华医学会器官移植分会围手术期管理学组委员，中国医师协会器官移植医师分会肾移植学组委员，中国医疗保健国际交流促进会肾脏移植分会委员，中国医疗保健国际交流促进会肝脏移植分会器官捐献学组副组长，湖北省医学会器官移植分会委员,武汉医学会器官移植分会常委。
教育履历	2003.09-2010.06武汉大学第一临床学院临床医学七年制，获学士，硕士学位 2010.09-2013.06武汉大学第一临床学院外科学博士研究生获博士学位
工作履历	2013.07-2015.06 武汉大学人民医院泌尿外科主治医师 2015.06-2016.11 武汉大学人民医院器官移植科，主治医师 2016.12-至今武汉大学人民医院器官移植科副主任医师 2020.11-至今武汉大学人民医院器官移植科副教授， 2020.12-至今武汉大学人民医院器官移植科党支部书记 2022.11-至今，武汉大学人民医院OPO办公室副主任
成果获奖	无
代表性论著	1.Guo J, Han S, Chen Q, Wang T, Yu B, Zhou J, Qiu T. Analysis of potential immune-related genes involved in the pathogenesis of ischemia-reperfusion injury following liver transplantation.Front Immunol. 2023 Mar 16;14:1126497. 2.Ding X, Wang T, Bai S, Yang M, Peng N, Qiu T, Liu Y。A Dual Heat Shock Protein Down-Regulation Strategy Using PDA/Cu/ICG/R Controlled by NIR "Switch" Enhances Mild-Photothermal Therapy Effect.Adv Healthc Mater。2023 Jun 9;e2300929. doi: 1 3.Chen Z, Hu F, Zhang Y, Zhang L, Wang T, Kong C, Hu H, Guo J, Chen Q, Yu B, Liu Y, Zou J, Zhou J, Qiu T. Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination. Front Immunol. 2023 May 26;14:1167667. doi: 10.3389/fimmu.2023.1167667. 4.Zhou J, Guo L, Ma T, Qiu T, Wang S, Tian S, Zhang L, Hu F, Li W, Liu Z, Hu Y, Wang T, Kong C, Yang J, Zhou J, Li H.N-Acetylgalactosaminyltransferase-4 protects against hepatic ischaemia/reperfusion injury via blocking ASK1 N-terminal dimerization. Hepatology. 2022 Jun;75(6):1446-1460. doi: 10.1002/hep.32202. Epub 2021 Dec 19. 5.Ding X, Wang T, Bai S, Wan Y, Zhu S, Li T, Peng N, Qiu T, Liu Y. Multifunction in One Nanoparticle for Anticancer Therapy: Bowl-Shaped Au@PDA Yolk-Shell NPs.ACS Appl Mater Interfaces. 2022 Jun 22;14(24):27733-27742. doi: 10.1021/acsami.2c07671 6.Jiangqiao Zhou, Tianyu Wang, Zhongbao Chen, Long Zhang, Jilin Zou, Xiaoxiong Ma, Tao Qiu#.Ubiquitin-specific peptidase 10 protects against hepatic ischaemic/reperfusion injury via TAK1 signalling , Front Immunol. 2020 Sep 29;11:506275. 7.Tao Qiu, Tianyu Wang, Jiangqiao Zhou#, Zhongbao Chen, Jilin Zou, Long Zhang, Xiaoxiong Ma.DUSP12 protects against hepatic ischemia and reperfusion injury dependent on ASK1-JNK/p38 pathway in vitro and in vivo.Clin Sci (Lond). 2020 Sep 18;134(17):2279-2294. doi: 10.1042/CS20191272. 8.Yuan Y, Qiu T, Wang T, Zhou J, Ma Y, Liu X, Deng H. The application of Temporary Ark Hospitals in controlling COVID-19 spread: the experiences of one Temporary Ark Hospital, Wuhan, China. J Med Virol. 2020 Oct;92(10):2019-2026. doi: 10.1002/jmv.25947. Epub 2020 Jun 29. 9.Qiu Tao, Wang Tianyu, Zhou Jiangqiao, Chen Zhongbao, Ma Xiaoxiong, Zhang Long, Zou Jilin.Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways. Int J Biol Sci 2019;15(8):1618-1629.doi:10.7150/ijbs.33323.June 10.Qiu T, Zhou J#, Wang T, Chen Z, Ma X, Zhang L, Zou J.Leukocyte immunoglobulin-like receptor B4 deficiency exacerbates acute lung injury via NF-κB signaling in bone marrow-derived macrophages.Biosci Rep. 2019 Jun 14;39(6)：BSR20181888. 11.Jiangqiao Zhou,Tao Qiu#,Tianyu Wang,Zhongbao Chen,Xiaoxiong Ma,Long Zhang,Jilin Zou,USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling,Clin Sci (Lond),2019,133(2):335-349.Jan 12.Jiangqiao Z#, Tao Q*, Zhongbao C, Xiaoxiong M, Long Z, Jilin Z, Tianyu W, Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma,Biochem Biophys Res Commun,2019,511(1):165-172.March

Name	Tao Qiu
Date of birth	Apr 1984
Department	Department of Organ Transplantation，Renmin Hospital, Wuhan University
Title	Associate professor；Associate chief physician；postgraduate tutor；Party branch secretary；Deputy director of OPO office
Email	qiutao@whu.edu.cn
TEL	027-88041911 transfer 81849 or 13995632367
Research Direction	1.Mechanisms of organ ischemia-reperfusion；2.Transplant Immune tolerance
Personal Profile	Professor Tao Qiu has been engaged in organ transplantation for more than 10 years, participated in and completed more than 1000 cases of various types of kidney transplantation. He has rich theoretical knowledge and clinical experience in the field of kidney transplantation, and is good at individualized medicine after kidney transplantation, BKV infection, rejection prevention and control. He has hosted or participated in more than 10 national, provincial and municipal scientific research projects, published 40 SCI papers, more than 30 papers in core journals, and participated in the compilation of 2 works. He has long been devoted to the research of transplantation immune tolerance and ischemia-reperfusion injury.
Selected Publications	1.Guo J, Han S, Chen Q, Wang T, Yu B, Zhou J, Qiu T. Analysis of potential immune-related genes involved in the pathogenesis of ischemia-reperfusion injury following liver transplantation.Front Immunol. 2023 Mar 16;14:1126497. 2.Ding X, Wang T, Bai S, Yang M, Peng N, Qiu T, Liu Y。A Dual Heat Shock Protein Down-Regulation Strategy Using PDA/Cu/ICG/R Controlled by NIR "Switch" Enhances Mild-Photothermal Therapy Effect.Adv Healthc Mater。2023 Jun 9;e2300929. doi: 1 3.Chen Z, Hu F, Zhang Y, Zhang L, Wang T, Kong C, Hu H, Guo J, Chen Q, Yu B, Liu Y, Zou J, Zhou J, Qiu T. Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination. Front Immunol. 2023 May 26;14:1167667. doi: 10.3389/fimmu.2023.1167667. 4.Zhou J, Guo L, Ma T, Qiu T, Wang S, Tian S, Zhang L, Hu F, Li W, Liu Z, Hu Y, Wang T, Kong C, Yang J, Zhou J, Li H.N-Acetylgalactosaminyltransferase-4 protects against hepatic ischaemia/reperfusion injury via blocking ASK1 N-terminal dimerization. Hepatology. 2022 Jun;75(6):1446-1460. doi: 10.1002/hep.32202. Epub 2021 Dec 19. 5.Ding X, Wang T, Bai S, Wan Y, Zhu S, Li T, Peng N, Qiu T, Liu Y. Multifunction in One Nanoparticle for Anticancer Therapy: Bowl-Shaped Au@PDA Yolk-Shell NPs.ACS Appl Mater Interfaces. 2022 Jun 22;14(24):27733-27742. doi: 10.1021/acsami.2c07671 6.Jiangqiao Zhou, Tianyu Wang, Zhongbao Chen, Long Zhang, Jilin Zou, Xiaoxiong Ma, Tao Qiu#.Ubiquitin-specific peptidase 10 protects against hepatic ischaemic/reperfusion injury via TAK1 signalling , Front Immunol. 2020 Sep 29;11:506275. 7.Tao Qiu, Tianyu Wang, Jiangqiao Zhou#, Zhongbao Chen, Jilin Zou, Long Zhang, Xiaoxiong Ma.DUSP12 protects against hepatic ischemia and reperfusion injury dependent on ASK1-JNK/p38 pathway in vitro and in vivo.Clin Sci (Lond). 2020 Sep 18;134(17):2279-2294. doi: 10.1042/CS20191272. 8.Yuan Y, Qiu T, Wang T, Zhou J, Ma Y, Liu X, Deng H. The application of Temporary Ark Hospitals in controlling COVID-19 spread: the experiences of one Temporary Ark Hospital, Wuhan, China. J Med Virol. 2020 Oct;92(10):2019-2026. doi: 10.1002/jmv.25947. Epub 2020 Jun 29. 9.Qiu Tao, Wang Tianyu, Zhou Jiangqiao, Chen Zhongbao, Ma Xiaoxiong, Zhang Long, Zou Jilin.Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways. Int J Biol Sci 2019;15(8):1618-1629.doi:10.7150/ijbs.33323.June 10.Qiu T, Zhou J#, Wang T, Chen Z, Ma X, Zhang L, Zou J.Leukocyte immunoglobulin-like receptor B4 deficiency exacerbates acute lung injury via NF-κB signaling in bone marrow-derived macrophages.Biosci Rep. 2019 Jun 14;39(6)：BSR20181888. 11.Jiangqiao Zhou,Tao Qiu#,Tianyu Wang,Zhongbao Chen,Xiaoxiong Ma,Long Zhang,Jilin Zou,USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling,Clin Sci (Lond),2019,133(2):335-349.Jan 12.Jiangqiao Z#, Tao Q*, Zhongbao C, Xiaoxiong M, Long Z, Jilin Z, Tianyu W, Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma,Biochem Biophys Res Commun,2019,511(1):165-172.March